Top Markets
#1 bitcastle Token bitcastle Token +151.43%
#2 MarsCoin MarsCoin +70.18%
#3 Palladium Network Palladium Network +53.05%
#4 Siren Siren +28.27%
#5 edgeX edgeX +23.02%
#6 Status Status +20.93%
#7 Useless Coin Useless Coin +18.68%
#8 Bedrock Bedrock +18.28%
#9 PondCoin PondCoin +15.49%
#10 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +15.19%
Coin of the day
bitcastle Token bitcastle Token
Instellingen
Taal
DUTCH
Valuta
USD
Thema
Oryzon Genomics S.A. Oryzon Genomics S.A.

Oryzon Genomics S.A.

ORY
Rang in aandelen #16830
Oryzon Genomics S.A., a clinical stage biopharmaceutical company, engages in... Oryzon Genomics S.A., a clinical stage biopharmaceutical company, engages in the discovery and development of epigenetics-based therapeutics for patients with cancer and CNS (central nervous system), oncology, and hematology disorders. Its clinical phase compounds include iadademstat (ORY-1001), a selective LSD1 inhibitor that is in Phase II trials for oncology; and vafidemstat (ORY-2001), a CNS-optimized LSD1 inhibitor, which is in Phase II trials for the treatment of CNS and psychiatric diseases. Its product candidates also comprise ORY-3001, an LSD1 inhibitor that is in preclinical development for the treatment of non-oncological diseases; and ORY-4001, a selective HDAC-6 inhibitor for the treatment of neurological disorders, such as Charcot-Marie-Tooth disease (CMT), amyotrophic lateral sclerosis (ALS), and others. It also has collaborations in precision medicine with Columbia University in New York and the Institute of Medical and Molecular Genetics (INGEMM) at La Paz Hospital in Madrid psychometrically characterize patients with mutations in the SetD1A or Shank3 genes; and Cooperative Research and Development Agreement (CRADA) to sponsor several clinical trials. The company was incorporated in 2000 and is based in Cornellà de Llobregat, Spain.
Aandeelprijs
$3.37
Marktkapitalisatie
$276.48M
Verandering (1 dag)
1.14%
Verandering (1 jaar)
10.00%
Land
ES
Handel Oryzon Genomics S.A. (ORY)

Categorie

Healthcare
Koersgeschiedenis voor Oryzon Genomics S.A. (ORY)
Hoogste slotkoers: $3.34 op 2026-09-01

Laagste slotkoers: $4.05 op 2015-12-01
Koersgeschiedenis van Oryzon Genomics S.A. van 2015 tot 2026
Jaarlijkse koersprestatie
Jaar Prestaties
2026 (TTM) -2.98%
2025 127.05%
2024 -28.98%
2023 -7.72%
2022 -20.86%
2021 -17.47%
2020 14.60%
2019 14.88%
2018 -16.03%
2017 -30.04%
2016 21.22%
2015 0.00%
Aandelenkoers van vergelijkbare bedrijven of concurrenten
Bedrijf Aandelenkoers Verandering 1jr% Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $556.43 40.29%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $1.05K 45.39%
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $152.82 535.43%
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $123.39 -8.70%
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $757.45 6.73%
CH